Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort

• Matthias Stoll ,

  * E-mail: Stoll.Matthias@mh-hannover.de

  Affiliation Infectious Diseases Unit, Medical University, Hanover, Germany

  ⨯
• Christian Kollan,

  Affiliation Robert Koch Institute, Berlin, Germany

  ⨯
• Frank Bergmann,

  Affiliation Charité University Medicine, Berlin, Germany

  ⨯
• Johannes Bogner,

  Affiliation University Hospital, Ludwig-Maximilian University, Munich/München, Germany

  ⨯
• Gerd Faetkenheuer,

  Affiliation University Hospital Cologne, Köln (Cologne), Germany

  ⨯
• Carlos Fritzsche,

  Affiliation University Hospital, Rostock, Germany

  ⨯
• Kirsten Hoeper,

  Affiliation Infectious Diseases Unit, Medical University, Hanover, Germany

  ⨯
• Heinz-August Horst,

  Affiliation University Schleswig Holstein, Kiel, Germany

  ⨯
• Jan van Lunzen,

  Affiliation University Hospital Eppendorf, Hamburg, Germany

  ⨯
• Andreas Plettenberg,

  Affiliation Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany

  ⨯
• Stefan Reuter,

  Affiliation University Hospital, Düsseldorf, Germany

  ⨯
• Jürgen Rockstroh,

  Affiliation University Hospital, Bonn, Germany

  ⨯
• Hans-Jürgen Stellbrink,

  Affiliation ICH Studycenter, Hamburg, Germany

  ⨯
• Osamah Hamouda,

  Affiliation Robert Koch Institute, Berlin, Germany

  ⨯
• Barbara Bartmeyer,

  Affiliation Robert Koch Institute, Berlin, Germany

  ⨯
•  [ ... ],
• and the ClinSurv Study Group

  ¶For more information on the ClinSurv Study Group please see the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]